Any cardiovascular disease resulting from atherosclerosis.
Comprehensive, easy-to-understand information about this condition
How we create this content →Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 8, 2026
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 8, 2026
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 8, 2026
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning atherosclerotic cardiovascular disease
Updated Jan 28, 2026
Argo Biopharma has initiated a phase 2b trial of its siRNA therapeutic BW-20829, targeting patients with elevated lipoprotein(a) levels. This global study marks a significant step in addressing cardiovascular risks associated with Lp(a).
The Million Hearts initiative encourages gift-giving that promotes heart health this holiday season. This campaign aims to raise awareness about cardiovascular disease prevention.
A recent CDC report indicates that cardiovascular disease rates are decreasing among adults with diabetes, highlighting improved health management. Additionally, there is a noted increase in the frequency of blood sugar monitoring among this population.